Literature DB >> 94763

The effects of metiamide and H1 receptor blocking agents on anaphylactic response in guinea-pigs.

C Advenier, B Mallard, M C Santais, F Ruff.   

Abstract

The effects of metiamide and of four H1 receptor blocking agents (mepyramine, promethazine, clemastine and ketotifene) on anaphylactic reaction were studied in the guinea-pig. The H1 blockers conferred partial protection which shows that with the experimental protocol utilized (challenge injection with high doses of antigen), histamine plays a lesser role than other mediators released or synthesized. Metiamide (30.0 mg/kg i.v.) noticeably enhanced the increase in pulmonary resistance observed during anaphylactic reaction and reduced the protective effect of the H1 antagonists on this parameter and on histamine release. These effects might be explained by an inhibition - at least partial - of the negative feed-back mechanism through which histamine controls its own release, or by a specific action of metiamide in high doses. The transient tachycardia initially observed in anaphylactic shock is partly related to stimulation of cardiac H2 receptors by the histamine released, since it is suppressed by metiamide.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 94763     DOI: 10.1007/bf01968112

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  35 in total

1.  The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock.

Authors:  W E BROCKLEHURST
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

2.  Mechanics of respiration in unanesthetized guinea pigs.

Authors:  M O AMDUR; J MEAD
Journal:  Am J Physiol       Date:  1958-02

3.  The action of metiamide in anaphylaxis in vivo in the guinea-pig [proceedings].

Authors:  P Goadby; M A Little
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

4.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

5.  Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

Authors:  P J Piper; J R Vane
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

6.  Inhibition of histamine release by histamine controlled by H2 receptor.

Authors:  L M Lichtenstein; E Gillespie
Journal:  Nature       Date:  1973-08-03       Impact factor: 49.962

7.  H2 receptor mediated inhibition of immediate type hypersensitivity reactions in vivo.

Authors:  J M Drazen; C S Venugopalan; N A Soter
Journal:  Am Rev Respir Dis       Date:  1978-03

8.  Pharmacological characterization of cardiac histamine receptors: sensitivity to H1-and H2-receptor agonists and antagonists.

Authors:  R Levi; N Capurro; C H Lee
Journal:  Eur J Pharmacol       Date:  1975-02       Impact factor: 4.432

9.  The effects of pentobarbitone and urethane on pulmonary airway resistance in guinea-pigs and their interactions with drugs.

Authors:  C Advenier; J R Boissier; S Ho; B Mallard; F Ruff
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

10.  BRONCHOCONSTRICTOR ACTION AND ANTAGONISM OF A SLOW-REACTING SUBSTANCE FROM ANAPHYLAXIS OF GUINEA-PIG ISOLATED LUNG.

Authors:  P A BERRY; H O COLLIER
Journal:  Br J Pharmacol Chemother       Date:  1964-08
View more
  3 in total

1.  Responses to histamine and selective H2-receptor agonists in lung parenchymal strips from normal and sensitized guinea-pigs.

Authors:  J Cortijo; C Sanz; M Perpiñá; J L Ortiz; J D Orón; J Esplugues; E J Morcillo
Journal:  Agents Actions       Date:  1989-08

2.  A new in vivo method for the measurement of repetitive anaphylactic responses in the guinea-pig.

Authors:  K M Bottomley; S Lewis; T J Rising; A Steward
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

3.  The effects of atropine on anaphylactic shock in the guinea-pig.

Authors:  C Advenier; B Mallard; M C Santais; F Ruff
Journal:  Agents Actions       Date:  1982-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.